NCT07249151

Brief Summary

Brief Summary This study, sponsored by the National Natural Science Foundation of China and conducted at the Emergency Department (ED) of Jiangnan University Affiliated Hospital, aims to optimize emergency care for critically ill patients via combining "early warning scoring" and "bedside rapid assessment". Why the Study? Delayed identification of emergency patients at high risk of deterioration worsens outcomes; traditional assessments often miss subtle deterioration signs. This study seeks a more efficient assessment approach to help clinicians recognize high-risk patients earlier and start targeted treatment faster. Eligibility 200-300 participants will be recruited from the hospital's ED for acute diseases (e.g., severe infection, heart failure, trauma). Inclusion: aged 18-80, with informed consent (or family consent if unable to communicate). Exclusion: severe mental illness, non-intervenable terminal illness. Study Process All participants receive routine emergency care. The research team uses a new combined assessment tool: first a 2-minute bedside rapid assessment (vital signs, consciousness, breathing), then early warning scoring to classify risk. Doctors adjust treatment priority based on results. The team records time from admission to treatment initiation and 72-hour condition changes. No additional invasive procedures/experimental drugs are used, and no extra cost for assessments. Potential Benefits Participants may get more timely, targeted emergency care (reducing deterioration risk and hospital stay). Study results will improve emergency care at this and other hospitals, benefiting more emergency patients. Study Leadership Principal Investigator: Dr. Jun Liu (Attending Physician, ED of Jiangnan University Affiliated Hospital) Responsible Party: Jiangnan University Affiliated Hospital (Sponsor) Ethical Approval: Approved by the hospital's Medical Ethics Committee (Approval No.: To be filled with actual number)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 17, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 25, 2025

Completed
Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

1.3 years

First QC Date

September 17, 2025

Last Update Submit

November 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • ICU-Level Organ Support or In-Hospital Mortality Within 24 Hours

    Composite endpoint defined as the occurrence of either "ICU-level organ support" or "in-hospital mortality" within 24 hours after EWS score ≥5 (T0). "ICU-level organ support" includes: invasive mechanical ventilation initiation, continuous vasopressor use for ≥30 minutes, or CRRT activation. "In-hospital mortality" refers to death occurring during the current hospitalization. Data are extracted from electronic medical records (EMR) and ICU information systems, with event time confirmed by the earliest timestamp of organ support initiation or death notification.

    From the time of patient admission (admission time) up to 24 hours after admission time.

Secondary Outcomes (5)

  • T3 Compliance Rate

    Within the first 24 hours from ED registration

  • Door-to-Key Intervention Time

    Within the first 24 hours from ED registration

  • 72-Hour ICU Admission Rate

    From T0 (time of enrollment or index event) until ICU admission or hospital discharge, whichever occurs first, assessed up to 72 hours post-T0.

  • 28-Day In-Hospital Mortality

    From patient ED registration up to 28 days after registration

  • Incidence of Over-Escalation and Delayed Escalation

    From T0 (initial escalation decision) until confirmation of intervention necessity or time limit deviation, whichever occurs first, assessed up to 72 hours post-T0.

Study Arms (2)

Optimized ED Bedside Nursing Protocol

EXPERIMENTAL

Arm 1 (Intervention: Optimized ED Assessment) 12 clusters (3 hospitals × 6 depts, day/night shifts) randomized to intervention in 10 phases. Participants get "mNEWS + structured bedside rapid assessment" at triage: 3-min standard assessment (2-min checks: BP, HR, RR, SpO₂, GCS, respiratory status; 1-min mNEWS for risk stratification). Staff prioritize treatment via results. Optimized protocol replaces conventional post-randomization.

Procedure: Optimized ED Bedside Nursing Protocol

Control Arm: Conventional Emergency Assessment

NO INTERVENTION

Control: Conventional ED Assessment Waitlist clusters keep routine assessment pre-randomization. Conventional process: vital sign recording (BP, HR, RR) + subjective severity judgment, no structured scoring/risk stratification. Clusters switch to optimized post-wait, but control data collected only during conventional implementation.

Interventions

A 3-minute standardized emergency nursing assessment exclusively performed by frontline ED nurses, integrating modified National Early Warning Score (mNEWS) and structured bedside checks. Implemented immediately after patient admission (pre-treatment initiation), it includes 2-minute evaluations of systolic BP, HR, RR, SpO₂, respiratory status, and GCS score, followed by 1-minute mNEWS calculation to stratify into low/medium/high risk-directly guiding care prioritization. Distinct from unstructured experience-based assessments or physician-led scoring tools, it's tailored for 24/7 shift-based cluster settings across multiple hospitals.

Optimized ED Bedside Nursing Protocol

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients will be eligible for enrollment if they meet all of the following conditions:
  • Age between 18 and 80 years at the time of presentation.
  • Presentation to the emergency department (ED) for acute medical evaluation.
  • Completion of at least one documented Early Warning Score (EWS) assessment upon ED admission or during the ED stay.

You may not qualify if:

  • Patients will be excluded if they meet any of the following criteria:
  • Do-not-resuscitate (DNR) orders or enrollment in a palliative/comfort care pathway at the time of presentation.
  • Cardiac arrest upon arrival to the ED (unresponsive, pulseless, requiring resuscitation without return of spontaneous circulation).
  • Transfer out of the hospital (to another institution or to the operating room for immediate surgery) within 24 hours of ED admission.
  • History of major cardiac surgery (e.g., coronary artery bypass grafting, valve replacement) or heart transplantation, as these conditions may alter baseline hemodynamics and limit EWS applicability.
  • Severe chronic organ dysfunction, including:
  • End-stage renal disease requiring maintenance dialysis; Severe hepatic insufficiency (Child-Pugh class C or equivalent); Advanced heart failure (New York Heart Association class IV).
  • Known allergy or contraindication to iodinated contrast media (if relevant laboratory or imaging assessments are required for outcome evaluation).
  • Pregnancy, due to altered physiological parameters and ethical considerations.
  • Incomplete or missing clinical records, preventing calculation of EWS or confirmation of study endpoints.
  • Duplicate enrollment due to repeated ED visits or readmissions during the study period (only the first eligible admission will be included).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wuxi Taihu Hospital; Affiliated Hospital of Jiangnan University; Wuxi Binhu District Traditional Chinese Medicine Hospital; Wuxi Xinwu District Traditional Chinese Medicine Hospital

Wuxi, Jiangsu, 214122, China

Location

Related Publications (5)

  • Covino M, Sandroni C, Della Polla D, De Matteis G, Piccioni A, De Vita A, Russo A, Salini S, Carbone L, Petrucci M, Pennisi M, Gasbarrini A, Franceschi F. Predicting ICU admission and death in the Emergency Department: A comparison of six early warning scores. Resuscitation. 2023 Sep;190:109876. doi: 10.1016/j.resuscitation.2023.109876. Epub 2023 Jun 17.

  • Churpek MM, Snyder A, Han X, Sokol S, Pettit N, Howell MD, Edelson DP. Quick Sepsis-related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical Deterioration in Infected Patients outside the Intensive Care Unit. Am J Respir Crit Care Med. 2017 Apr 1;195(7):906-911. doi: 10.1164/rccm.201604-0854OC.

  • Candel BGJ, Nissen SK, Nickel CH, Raven W, Thijssen W, Gaakeer MI, Lassen AT, Brabrand M, Steyerberg EW, de Jonge E, de Groot B. Development and External Validation of the International Early Warning Score for Improved Age- and Sex-Adjusted In-Hospital Mortality Prediction in the Emergency Department. Crit Care Med. 2023 Jul 1;51(7):881-891. doi: 10.1097/CCM.0000000000005842. Epub 2023 Mar 23.

  • Arevalo-Buitrago P, Morales-Cane I, Olivares Luque E, Godino-Rubio M, Rodriguez-Borrego MA, Lopez-Soto PJ. Early detection of risk for clinical deterioration in emergency department patients: validation of a version of the National Early Warning Score 2 for use in Spain. Emergencias. 2022 Dec;34(6):452-457. English, Spanish.

  • Nannan Panday RS, Minderhoud TC, Alam N, Nanayakkara PWB. Prognostic value of early warning scores in the emergency department (ED) and acute medical unit (AMU): A narrative review. Eur J Intern Med. 2017 Nov;45:20-31. doi: 10.1016/j.ejim.2017.09.027. Epub 2017 Oct 7.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Attending Physician

Study Record Dates

First Submitted

September 17, 2025

First Posted

November 25, 2025

Study Start

May 1, 2024

Primary Completion

August 30, 2025

Study Completion

September 16, 2025

Last Updated

November 25, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

De-identified individual participant data (IPD) are pending final quality inspection, consistency verification, and standardized organization; premature sharing may lead to the use of unvalidated data, thereby compromising the reliability of secondary analyses. The current IPD will support subsequent sub-studies (e.g., disease phenotype-stratified analysis, long-term outcome correlation research). Temporary non-sharing of data prevents the redundant use of core data and ensures the integrity of this research series. Upon completion of the aforementioned tasks (final data verification, implementation of follow-up sub-studies, confirmation of data security), the team will re-evaluate the IPD sharing arrangement. If feasible, the relevant arrangements will be promptly disclosed via ClinicalTrials.gov.

Locations